In vitro type-1 and type-2 cytokine production in systemic lupus erythematosus: Lack of relationship with clinical disease activity

Lupus

Volumn 5, Issue 2, 1996, Pages 139-145

  Barcellini, W ^a,b   Rizzardi, G P ^a   Borghi, M O ^a   Nicoletti, F ^a   Fain, C ^a   Del Papa, N ^a   Meroni, P L ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Cytokines; Polyclonal B cell activation; sCD23; SLE

Indexed keywords

AZATHIOPRINE; CD23 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOKINE; DNA ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; METHOTREXATE; POLYCLONAL ANTIBODY;

ADULT; ANTIBODY PRODUCTION; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE; MALE; MONONUCLEAR CELL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0029964272     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339600500209     Document Type: Article

References (37)

1. Linker-Israeli M. Cytokine abnormalities in human lupus. Clin lmmunol Immunopath 1992; 63: 10-2.
2. Via CS, Handweger BS. B-cell and T-cell function in systemic lupus erythematosus. Curr Opin Rhematol 1993; 5: 570-4.
3. Tanaka Y, Saito K, Shirakawa F, et al. Production of B cell-stimulating factors by B cells in patients with systemic lupus erythematosus. J Immunol 1988; 141: 3043-9.
4. Tan PL, Blumenstein M, Yeoman M, Watson JD B cell lymphokines in human systemic lupus erythematosus. Ann Rheum Dis 1989; 48: 941-5.
5. Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinenberg JR. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 1991; 147: 117-23.
6. Mosmann TR. Cytokine secretion phenotypes of TH cells: how many subsets, how much regulation? Res Immunol 1991; 142: 9-13.
7. Spits H, de Vries JE. Interleukin-10. Curr Opin Immunol 1992; 4: 314-20.
8. Trinchieri G, D'Andrea A, Manthrasalam R, et al. Natural killer cell stimulatory factor (NKSF) or interleukin-12: a heterodimeric cytokine produced by accessory cells and with regulatory functions on T and NK cell responses. In. Romagnani S, Mosmann RT, Abbas AK, Eds. New advances on cytokines. New York: Raven Press, 1993; 325-33.
9. Clerici M, Shearer GM. The Thl-Th2 hypothesis of HIV infection: new insights. Immunology Today 1994; 15: 575-81.
10. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
11. Vitali C, Bencivelli W, Isemberg DA, et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. IL Identification of the variables indicative of disease activity and their use in the development of an activity score. Clin Exp Rheum 1992; 10: 541-7.
12. Fish F, Ziff M. A sensitive solid phase microradioimmunoassay for anti-double stranded DNA antibodies. Arthritis Rheum 1981; 24: 534-43.
13. Meroni PL, De Bartolo G, Barcellini W, et al. Anti-ribosomal ribonucleoprotein autoantibodies in SLE. J Clin Immunol 1984; 4: 45-54.
14. Van Venrooij WJ, Charles P, Maini RN. The consensus workshops for the detection of autoantibodies to intracellular antigens in rheumatic diseases. J Immunol Methods 1991; 140: 181-9.
15. Boyum A. Isolation of mononuclear cell and granulocyte from human blood. Scand J Clin Lab Invest 1968; 21: 77-89.
16. Barcellini W, Meroni PL, Borghi MO, et al. In vivo immunopotentiating activity of thymopentin in aging humans: modulation of IL-2 receptor expression. Clin Immunol Immunopath 1988; 48: 140-9.
17. Meroni PL, Barcellini W, Sguotti C, et al. Immunomodulating activity of RU41470: in vitro and in vivo studies on human lymphocytes. Int J Immunopharmacol 1987; 9: 185-90.
18. Salaman MR, Seifert MH, Isemberg DA. B lymphocyte activation in systemic lupus erythematosus: spontaneous production of IgG antibodies to DNA and environmental antigens in cultures of blood mononuclear cells. Clin Exp Immunol 1988; 73: 430-35.
19. Banchereau J. Interleukin-4. In: Thompson A, ed. The cytokine handbook. London: Academic Press Limited, 1991; 119-48.
20. Delespesse G, Sarfati M, Peleman R. Influence of recombinant IL-4, IFN-α and IFN-γ on the production of human IgE-binding factor (soluble CD23). J Immunol 1989; 142: 134-8.
21. Yukawa K, Kikutani H, Owaki K, et at. A B cell-specific differentiation antigen, CD23, is a receptor for IgE (FcsR) on lymphocytes. J Immunol 1987; 138: 2576-80.
22. Delespesse G, Suter U, Mossalayi D, et al. Expression, structure and function of the CD23 antigen. Adv Immunol 1991; 49: 149-91.
23. Gordon J. CD23 and B cell activation. Clin Exp Allergy 1992; 22: 199-204.
24. Gordon J, Flores-Romo L, Cairns JA, et al CD23: a multifunctional receptor/lymphokine? Immunol Today 1989; 5: 153-7.
25. Bansal AS, Oilier W, Marsh MN, Pumphrey RSH, Wilson PB. Variations in serum sCD23 in conditions with either enhanced humoral or cell-mediated immunity. Immunology 1993; 79: 285-9.
26. Rezonzew R and Newkirk MM. Impaired release of sCD23 by activated B-cells and RA patients. Clin Immunol Immunopath 1994; 71: 156-163.
27. Kitani A, Hara M, Hirose T, et al. Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression. Clin Exp Immunol 1992; 88: 75-83.
28. Alarcon-Riquelme ME, Möller G, Fernàndez C. Macrophage depletion decreases IgG anti-DNA in cultures from (NZB × NZW)F1 spleen cells by eliminating the main source of IL-6. Clin Exp Immunol 1993; 91: 220-5.
29. Llorente L, Richaud-Patin Y, Wijdenes J, et al. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur Cytokine Netw 1993; 4: 421-30.
30. Hirano T. Interleukin-6. In: Thomson A, ed. The cytokine handbook. London: Academic Press Limited, 1991; 169-190.
31. Roussel F, Garcia E, Defrance T, et al. IL-10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992; 89:1890-3.
32. 1 mice. J Exp Med 1994; 179: 305-10.
33. Spronk PE, ter Borg EJ, Limburg PC, Kallenberg CGM. Plasma concentration of IL-6 in systemic lupus erythematosus ; an indicator of disease activity? Clin Exp Immunol 1992; 90: 106-10.
34. Gabay C, Roux-Lombard P, de Moerloose P, Dayer JM, Vischer T, Guerne PA. Absence of correlation between interleukin-6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis. J Rheumatol 1993; 20: 815-21.
35. Clerici M, Shearer G. A TH1→TH2 switch is a critical step in the etiology of HIV infection, Immunol Today 1993; 14: 107-10.
36. Barcellini W, Rizzardi GP, Borghi MO, Fain C, Lazzarin A, Meroni PL, Th1 and Th2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. AIDS 1994; 8: 757-62.
37. Schattner A. Short analytical review. Lymphokines in autoimmunity - A critical review. Clin Immunol Immunopathol 1994; 70: 177-189.